Therapeutic Strategy for Differentiated Thyroid Carcinoma in Japan Based on a Newly Established Guideline Managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons

Abstract

It is important to treat DTC patients individually according to their clinicopathological features rather than uniformly. We hope that policies regarding the treatment of DTC patients in Western countries and Japan will find the optimal compromise in the future, leading to the best treatments for patients with thyroid carcinoma all over the world.